Lumaquin-Yin, Dianne http://orcid.org/0000-0002-5285-0467
Montal, Emily
Johns, Eleanor http://orcid.org/0000-0001-6802-041X
Baggiolini, Arianna
Huang, Ting-Hsiang
Ma, Yilun
LaPlante, Charlotte
Suresh, Shruthy
Studer, Lorenz http://orcid.org/0000-0003-0741-7987
White, Richard M. http://orcid.org/0000-0001-9099-9169
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01CA229215, 5F31AR079215)
American Cancer Society
Melanoma Research Alliance
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 15 March 2022
Accepted: 17 May 2023
First Online: 2 June 2023
Competing interests
: R.M.W. is a paid consultant to N-of-One Therapeutics, a subsidiary of Qiagen. R.M.W. receives royalty payments for the use of the casper line from Carolina Biologicals. L.S. is co-founder and consultant of BlueRockTherapeutics and is listed as an inventor on a patent application by Memorial Sloan Kettering Cancer Center related to melanocyte differentiation from human pluripotent stem cells (WO2011149762A2). D.L., E.M., E.J., A.B., Y.M., C.L., T.H., and S.S. declare no competing interests.